{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:32:24Z","timestamp":1794645144891,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ijantimicag.2013.02.022","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T02:12:40Z","timestamp":1366164760000},"page":"527-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004\u20132010"],"prefix":"10.1016","volume":"41","author":[{"given":"Arta","family":"Balode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volga","family":"Punda-Poli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Dowzicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0005","first-page":"137","article-title":"Antibiotic resistance mechanisms of clinically important bacteria","volume":"47","author":"Giedraitien\u0117","year":"2011","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0010","first-page":"278","article-title":"Changes in antibiotic resistance level of nosocomial Pseudomonas aeruginosa isolates in the largest university hospital of Lithuania","volume":"47","author":"Adukauskien\u0117","year":"2011","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0015","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2010. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, Sweden: ECDC; 2011."},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0020","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1128\/JCM.02394-08","article-title":"Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia","volume":"47","author":"Goic-Barisic","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0025","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1016\/j.transproceed.2007.08.045","article-title":"Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004\u20132005","volume":"39","author":"M\u0142ynarczyk","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0035","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M7-A8. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0040","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1469-0691.2006.01578.x","article-title":"EUCAST technical note on tigecycline","volume":"12","author":"Kahlmeter","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0045","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010."},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0050","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement (June 2010 update). Document M100-S20U. Wayne, PA: CLSI; 2010."},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1179\/joc.2010.22.3.147","article-title":"Antimicrobial susceptibility and \u03b2-lactamase production of selected Gram-negative bacilli from two Croatian hospitals: MYSTIC study results","volume":"22","author":"Bedenic","year":"2010","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0060","first-page":"478","article-title":"Antimicrobial resistance profile of E. coli and Klebsiella spp. from urine in the Infectious Diseases Hospital Ia\u015fi [in Romanian]","volume":"112","author":"Miftode","year":"2008","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11597960-000000000-00000","article-title":"Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy","volume":"72","author":"Schultsz","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: changing the face of ESBLs in Europe","volume":"59","author":"Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0075","first-page":"152","article-title":"Prevalence of ESBL-positive Enterobacteriaceae in large Moravian hospitals (Czech Republic)","volume":"16","author":"Kol\u00e1\u0159","year":"2010","journal-title":"Klin Mikrobiol Infekc Lek"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0080","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1099\/jmm.0.021972-0","article-title":"Molecular characterization of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from hospitals in Lithuania","volume":"59","author":"Seputiene","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1556\/AMicr.57.2010.1.4","article-title":"Investigation of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae outbreaks in Hungary between 2005 and 2008","volume":"57","author":"Szil\u00e1gyi","year":"2010","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0090","first-page":"9","article-title":"Dissemination of the KPC carbapenemase producing Klebsiella pneumoniae in a hospital in Warsaw, Poland","volume":"62","author":"Piekarska","year":"2010","journal-title":"Med Dosw Mikrobiol"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0095","first-page":"62","article-title":"Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and\/or DHA-1 \u03b2-lactamases in a Czech hospital","volume":"309","author":"Chud\u00e1ckov\u00e1","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10096-010-0921-3","article-title":"Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary","volume":"29","author":"T\u00f3th","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2013.02.022_bib0105","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/324525","article-title":"Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999\u20132000","volume":"34","author":"Thornsberry","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2013.02.022_bib0110","doi-asserted-by":"crossref","first-page":"iv43","DOI":"10.1093\/jac\/dkr076","article-title":"Methicillin-resistant Staphylococcus aureus: the European landscape","volume":"66","author":"Johnson","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0115","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1556\/OH.2011.29205","article-title":"Changes in the incidence of multiresistant pathogens and its consequences in the intensive care unit","volume":"152","author":"Szucs","year":"2011","journal-title":"Orv Hetil"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0120","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/medicina46070071","article-title":"Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality","volume":"46","author":"Vitkauskien\u0117","year":"2010","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/medicina47070051","article-title":"Changes in the dependence of Pseudomonas aeruginosa O serogroup strains and their resistance to antibiotics in a university hospital during a 5-year period","volume":"47","author":"Vitkauskien\u0117","year":"2011","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MCC.0b013e32834c9d87","article-title":"Recent trends in antibiotic resistance in European ICUs","volume":"17","author":"van Duijn","year":"2011","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0135","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijantimicag.2011.02.004","article-title":"Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009","volume":"37","author":"Dowzicky","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.02.022_bib0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clinthera.2011.11.023","volume":"34","author":"Bertrand","year":"2012","journal-title":"Clin Ther"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913000836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913000836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T14:07:55Z","timestamp":1562940475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0924857913000836"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.02.022","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004\u20132010","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}